Helping MedTech companies move pharmaceutical partnerships from promising conversations to signed agreements.
20+ years commercializing innovative medical technologies • Purdue Mechanical Engineer • $500M+ in enterprise value creation
Many MedTech companies have compelling technology, strong technical relationships, and active pharmaceutical discussions—yet still struggle to advance from interest to commitment.
The challenge is rarely the technology.
It is understanding how pharmaceutical companies evaluate opportunities, align stakeholders, and ultimately make partnership decisions.
About JL Estep Executive Advisory
I’m a Purdue-trained mechanical engineer and strategic business development executive with more than 20 years of experience helping innovative medical technology companies create enterprise value through commercialization and pharmaceutical partnerships.
Trusted by global MedTech leaders to navigate commercialization and strategic pharmaceutical partnerships.
Myexperience spans drug delivery, medical devices, diagnostics, commercialization strategy, and pharmaceutical partnerships. Throughout my career, I have contributed to commercial strategies and strategic partnerships supporting more than $500 million in enterprise value creation.
I am also Founder & CEO of ScreenHER, applying this experience to build a next-generation women’s health diagnostics platform that expands access to earlier cancer detection.
Helping leadership teams navigate the commercial and organizational complexity behind successful pharmaceutical partnerships.
“Strong technical interest doesn’t always translate into commercial commitment. Successfully navigating executive stakeholders and internal decision-making often determines whether a partnership moves forward.”
— A common challenge shared by MedTech business development leaders
How I Help
I work with MedTech leadership teams to strengthen strategic pharmaceutical partnerships through:
- Develop partnership strategy
- Strengthen executive engagement
- Refine commercial positioning
- Navigate complex stakeholder environments
- Prepare for high-value pharmaceutical meetings
- Re-engage stalled partnership opportunities
- Support long-cycle business development efforts
Engagements range from strategic advisory and fractional business development leadership to focused project support.
Unlike traditional business development consultants, I bring the perspective of both a commercialization executive and a current MedTech founder navigating today’s partnering environment.
Typical Engagements
Examples include:
- Preparing executive teams for strategic pharmaceutical partnership meetings
- Developing partnership strategy for innovative MedTech platforms
- Re-engaging stalled pharmaceutical opportunities
- Stakeholder mapping and executive engagement planning
- Commercial positioning for platform technologies
- Fractional strategic business development leadership
- CEO and executive advisory for commercialization strategy
Who I Work With
Drug Delivery Innovators
Medical Device Manufacturers
Diagnostics Companies
Combination Product Developers
CDMOs
Health Technology Companies
Venture Capital Investing in Deep Health Tech
Let’s Talk
Whether you’re preparing for an important pharmaceutical partnership discussion or looking to strengthen your long-term partnering strategy, I’d welcome a brief conversation.
Schedule a 15-minute conversation below:
Jennifer L. Estep
Principal, JL Estep Strategic Biopharma & MedTech Consulting